Salute e Benessere

Casino Group Communication

Communication by the Casino Group Paris, 26 June 2023Information provided to the parties involved in the conciliation proceedings As part of the discussions conducted by Casino Group under the aegis of the conciliators ( conciliateurs ) appointed on 25 May 2023 by the Paris Commercial Court, Casino has shared with EPGC, Fimalac, 3F and certain creditors under a confidentiality agreement the key strategic and prospective financial information set out in sections 2 and 3 of the...
Nasdaq GlobeNewswire
26/06/2023

Global Phenacetin Market Set to Show Significant Growth by 2031, Driven by…

Download PDF Sample here:https://dataintelo.com/request-sample/?reportId=46044 The report segments the global phenacetin market by type into Purity 99%, Purity 99.5%, and Other. Depending on the application, the market is classified into Pharmaceuticals, Research and Development (R&D), Chemical Industry, and Others. The demand for phenacetin in pharmaceutical manufacturing, especially in the production of paracetamol and other related drugs, will play a crucial role in...
PR Newswire
26/06/2023

Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at…

STOCKHOLM, June 25, 2023 /PRNewswire/ -- Pivotal data from the Phase 3 XTEND-Kids study evaluating efanesoctocog alfa [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein] once-weekly prophylaxis in previously treated patients younger than 12 years of age with severe haemophilia A were presented today in a late-breaking session at the Annual Meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Montreal, Canada. STOCKHOLM,June 25, 2023/PRNewswire/ --...
PR Newswire
25/06/2023

Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly…

ALTUVIIIO TM late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosingXTEND-Kids data confirm the efficacy and safety profile of ALTUVIIIO with simple, weekly 50 IU/kg dosing for both adults and childrenALTUVIIIO's expanding evidence of a first and best-in-class profile supports Sanofi's commitment to delivering paradigm shifting therapies for Rare DiseasesParis , June 25 , 2023...
Nasdaq GlobeNewswire
25/06/2023

MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2…

MoonLake Immunotherapeutics achieves landmark milestone with positive Phase 2 results for Nanobody ®sonelokimab in hidradenitis suppurativaFirst placebo-controlled randomized trial in HS to report positive topline results using HiSCR75 as the primary endpointPrimary endpoint HiSCR75 met with 29 percentage points (ppt) delta vs placebo (p=0.0002) at week 12, setting a new bar in HSHiSCR50 met with 38 ppt delta vs placebo (p<0.0001), greater delta than observed for any...
Nasdaq GlobeNewswire
25/06/2023

Sobi successfully completes tender offer for all outstanding shares of common…

The tender offer expired as scheduled at one minute after 11:59 p.m., Eastern Time on June 23, 2023 (12:00 midnight, Eastern Time, on June 24, 2023). As of the expiration, 110,640,230 shares of common stock of CTI had been validly tendered and not validly withdrawn, representing approximately 83.8 percent of CTI's outstanding shares of common stock, according to the depositary for the tender offer. The conditions to the tender offer were satisfied, and Sobi and Cleopatra have accepted for…
PR Newswire
24/06/2023

Inventiva announces the presentation of a scientific abstract at the 83rd…

Daix (France), Long Island City (New York, United States) , June 24 , 2023– Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases with significant unmet medical needs, today announced that the abstract “Lanifibranor Improves Markers of Cardiometabolic Health in Patients with NASH and Type 2 Diabetes, Correlated...
Nasdaq GlobeNewswire
24/06/2023

Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder…

(NASDAQ: ENOB).Enochian BioSciences Inc., a company developing gene-modified cell immunotherapies for cancer and infectious diseases, wishes to advise that its 2023 Annual Stockholder Meeting (the “Annual Meeting”), which was scheduled to be held yesterday, June 22, 2023 at 12:00 p.m. Eastern Time, was convened and adjourned, without any business being conducted, due to the lack of the required quorum. As a result of the required quorum not being present, the Annual Meeting has been...
Nasdaq GlobeNewswire
23/06/2023

AC Immune Holds Annual General Meeting of Shareholders

AC Immune Holds Annual General Meeting of ShareholdersShareholders approved all resolutions as proposed by the Board of Directors Lausanne, Switzerland, June 23, 2023– AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that the Company held its Annual General Meeting per Swiss law. Shareholders cast their votes in person at the Annual General Meeting or through the Independent Proxy...
Nasdaq GlobeNewswire
23/06/2023

ERYTECH announces the approval of the merger with Pherecydes and reports the…

ERYTECHannounces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder's Meeting held on June 23 , 2023All resolutions voted with a large majority according to Board of Directors recommendationsCompany renamed Phaxiam Therapeutics, creating a world leader in phage therapy Lyon (France), June23 , 2023– ERYTECH Pharma (Euronext Paris & Nasdaq: ERYP) announced today...
Nasdaq GlobeNewswire
23/06/2023

INOVIO Announces Notice of Pendency and Proposed Settlement of Stockholder…

Plymouth Meeting, Pa., June23, 2023(GLOBE NEWSWIRE) --INOVIO (NASDAQ:INO) has released the following pursuant to an order of the UNITED STATES DISTRICT COURT EASTERN DISTRICT OF PENNSYLVANIA: UNITED STATES DISTRICT COURTEASTERN DISTRICT OF PENNSYLVANIAIN RE INOVIO PHARMACEUTICALS, INC. DERIVATIVE LITIGATIONLead Case No. 2:20-cv-01962-GJP NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDERDERIVATIVE ACTIONS TO: ALL RECORD HOLDERS AND...
Nasdaq GlobeNewswire
23/06/2023

Casino Group: Selling price of the remainder of Casino's stake in Assai

Selling price of the remainder of Casino's stake in Assai Paris, 23 June 2023Casino Group announces today the completion of the sale of its residual stake in Assaí announced on 22 June 2023.As part of the transaction, 157,582,850 Assaí common shares held by Casino Group, representing 11.7% of Assaí's share capital, were allocated at a selling price of BRL 13.38 per share, for a total gross amount of BRL 2,108 million (EUR 404 million 1 ). Net proceeds after costs and taxes are...
Nasdaq GlobeNewswire
23/06/2023

New Phase 3 data with aprocitentan to be presented at the European Society of…

Allschwil, Switzerland – June 23, 2023Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertension, will be presented as an oral presentation by Prof. Markus Schlaich, MD, at the European Society of Hypertension's 32 ndEuropean Meeting of Hypertension and Cardiovascular Protection, taking place in Milan, Italy, 23-26, 2023.The presentation...
Nasdaq GlobeNewswire
23/06/2023

Smart Pills Market worth $1.1 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=840 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=840 Browse in-depth TOC on "Smart Pills Market"104 - Tables33 - Figures153 - Pages Smart Pills Market Scope: The vital sign monitoring segment has accounted for the second largest share of the market during the forecast period Based on application, targeted medicine delivery,...
PR Newswire
23/06/2023

Global Air Sampler Market to Surpass USD 629 Mn By 2031| Growth Market Reports

Key Market Players Profiled in the Report Key Market Players Profiled in the Report Download PDF Sample here: https://growthmarketreports.com/request-sample/5321 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include types, applications, and competitor analysis. This report also includes a complete analysis of...
PR Newswire
23/06/2023

Global Remifentanil Hydrochloride Market to Surpass USD 346.7 Mn By 2031| Growth…

Download PDF Sample here: https://growthmarketreports.com/request-sample/5252 Download PDF Sample here: https://growthmarketreports.com/request-sample/5252 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include types, application, distribution channel, and competitor analysis. This report also includes a complete...
PR Newswire
23/06/2023

Global Plastic Pre-Filled Syringes Market to Surpass USD 4.28 Bn by 2031| Growth…

Download PDF Sample here: https://growthmarketreports.com/request-sample/5247 Download PDF Sample here: https://growthmarketreports.com/request-sample/5247 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include product, polymer type, design, application, end-user, and competitor analysis. This report also includes a...
PR Newswire
23/06/2023

Bavarian Nordic to Supply Smallpox Vaccines for EU Strategic Reserve

COPENHAGEN, Denmark, June 23, 2023– Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded a contract valued at EUR 10 million to supply its smallpox vaccine to rescEU, a strategic reserve within the European Union (EU) which aims to strengthen the EU's ability to respond to biological threats in the future. The strategic stockpile has been established to enable rapid deployment to EU member states and other countries participating in the EU Civil Protection Mechanism of...
Nasdaq GlobeNewswire
23/06/2023

Clario and Sleepiz AG bring innovative sleep and respiratory data collection…

Leveraging Sleepiz's cutting-edge technology, Clario provides its customers with additional endpoints in their clinical trials, contributing to a more comprehensive and detailed understanding of patients' sleep and respiratory conditions. This innovative approach offers an unprecedented opportunity for researchers and clinicians to gain deeper insights into the impact of their approaches on sleep-related diseases, respiratory health and disease progression. Leveraging Sleepiz's cutting-edge...
PR Newswire
23/06/2023

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Jonathan Milner issues Open Letter to shareholders of Abcam plcHighlights Abcam Board's track record of failing to pursue strategic M&A opportunitiesand lack of incentive to drive share performanceUrges all ADS shareholders to vote 'FOR' all of Milner's proposals on the BLUE proxy card by10am EST on 6 July 2023ahead of the Extraordinary General Meeting on 12 July 2023CAMBRIDGE, England, 23 June 2023– Jonathan Milner, the founder and one of the...
Nasdaq GlobeNewswire
23/06/2023

European Wellness Signs MOU with Tianyou to Expand Education, Research and…

One of the objectives of this joint effort is the establishment of "European Wellness Centers of Excellence for Biological Regenerative Medicine." The first center will be a European Wellness-Academy and branded integrative medicine, wellness, and aesthetic facility. A second center will focus on operating and providing premium patient consultation for healthcare practitioners across China, with the aim of recommending and aiding local patients interested in pursuing advanced methods…
PR Newswire
23/06/2023

OMRON Healthcare at ESH 2023 Congress

Image: Exhibition booth (for illustration purposes only):https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202306216488/_prw_PI3lg_1tfyS8Kd.jpg Image: Exhibition booth (for illustration purposes only):https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/202306216488/_prw_PI3lg_1tfyS8Kd.jpg Under the theme of "There's always room for inspiration," the Company is showcasing a collection of innovative blood pressure monitors, including Complete (TM), an upper-arm blood pressure...
PR Newswire
23/06/2023

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Regulated InformationLeuven, BELGIUM, Boston, MA, US – June 23 , 2023 – 8 .00AM CETOxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on June 19, 2023,...
Nasdaq GlobeNewswire
23/06/2023

SK pharmteco doubles viral vector production capacity in Europe

Yposkesi's second bioproduction site is situated in its Genopole campus, the largest biotech cluster in France. The newly completed site is a 5,000 m2 facility designed in accordance with current Good Manufacturing Practices (GMP) guidelines of the US and Europe. Together with the first bioproduction site, which is also located in the Genopole campus, Yposkesi now boasts one of Europe's largest biomanufacturing facility for C> that spans 10,000 m2. Yposkesi's second bioproduction site is...
PR Newswire
23/06/2023
Altri  Comunicati